Navigation Links
Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
Date:7/13/2014

Columbus, OH (PRWEB) July 13, 2014

A Xarelto lawsuit webpage has been launched by Wright & Schulte LLC to provide consumers with the most current information regarding serious internal bleeding that can sometimes accompany use of the blood-thinning medication, as well as the growing number of Xarelto bleeding lawsuits pending in courts around the country. The law firm is now offering free legal evaluations to anyone who may have suffered from life-threatening internal bleeding and related complications while using Xarelto, including:

  •     Gastrointestinal Bleeding
  •     Cerebral Hemorrhage
  •     Heart Attack
  •     Stroke
  •     Blood Clots
  •     Death

Xarelto is a blood thinner that is used for a number of indications, including the prevention of blood clots related to atrial fibrillation, and the treatment of dangerous blood clots called deep vein thrombosis and pulmonary embolism. It is also given to patients who have just had hip or knee replacement surgery to reduce the risk of blood clots in the legs and lungs. Xarelto was approved by the U.S. Food & Drug Administration (FDA) in 2011, and is manufactured by Bayer HealthCare. Janssen Pharmaceutical, a division of Johnson & Johnson, markets Xarelto in the U.S.
(fda.gov/downloads/Drugs/DrugSafety/
UCM280333.pdf, FDA, March 2014)

All blood thinners, including Xarelto, can cause patients to suffer internal hemorrhaging. However, there currently exists no antidote to reverse Xarelto bleeding. Since its approval, the drug has been the subject of several FDA safety alerts. In August 2013, a boxed warning was added to the Xarelto label advising that premature discontinuation of the drug increases the risk of thrombotic events. The FDA also warned that epidural or spinal hematomas with the potential to cause long-term or permanent paralysis could occur in Xarelto patients who receive anesthesia or undergo spinal puncture.
(fda.gov/safety/medwatch/safetyinformation/ucm367392.htm, FDA, March 2014)

According to a report published by Reuters last month, at least 10 Xarelto lawsuit claims have been filed in U.S. courts on behalf of patients who may have been injured by the blood thinner. Most recently, a Florida woman filed a wrongful death lawsuit on behalf of her husband, who allegedly died due to uncontrollable bleeding caused by Xarelto. Among other things, the complaint, which was filed on June 23, 2014 in U.S. District Court, Southern District of Florida, claims that the manufacturers of Xarelto failed to warn that there was no reversal agent for Xarelto bleeding. The lawsuit further alleges that Xarelto is unreasonably dangerous and defective, and points out that safer alternatives exist, such as warfarin, which have reversal agents for internal bleeding. (Case 0:14-cv-61448-JAL)
(reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614, June 14, 2014)

The attorneys of Wright & Schulte LLC believe that additional Xarelto lawsuits involving similar allegations will be filed against the manufacturers of this medication in the coming months. The Firm is offering free, no-obligation legal reviews to anyone who suffered serious internal bleeding and related complications due to their use of Xarelto. To learn more, or to arrange for a free legal consultation with an attorney at Wright & Schulte LLC, please visit yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Xarelto lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at http://www.prweb.com/releases/2014/07/prweb12013070.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
2. DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure
3. DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant
4. Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns
5. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing
6. Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators
7. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
8. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal C.R. Bard Litigation
9. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
10. Best Transvaginal Mesh Attorneys? LawsuitLegal.com Now Accepting Surgical Mesh Failure Victim Inquiries
11. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Recall Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... In ... innovative EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 ... – with nearly 2,000 consumers (and counting) already backing the campaign. , ...
(Date:3/24/2017)... ... March 24, 2017 , ... Viewers who like to ... critical historical facts, cultural practices, goods, services, and societal issues tend to appreciate and ... into the popular practice of utilizing running events for causes around the world. ...
(Date:3/24/2017)... , ... March 24, 2017 , ... “End Time GPS”: ... salient events will interrelate. “End Time GPS” is the creation of published author, ... expert while working on military munitions and space-vehicle projects. Now, at age ninety-one, he ...
(Date:3/23/2017)... CO (PRWEB) , ... March 23, 2017 , ... A ... bar for entry into teacher preparation programs. The NCTQ report suggests, based on a ... entry requirements would significantly improve teacher quality in the U.S. It argues that this ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The IoT (Internet ... WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... the IoT will have a value anywhere from $4 trillion to $11 trillion dollars ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , Latin ... provided for the period 2015 through 2022. Also, a six-year historic analysis ...
(Date:3/24/2017)... -- HealthMine surveys with 9,250 insured consumers fielded from February ... want help from their plans in five key areas: ... 2) help closing gaps in care, 3) better digital ... relevant, real-time guidance. Meeting these needs is essential to ... A Reason to Stay Engaged in Health ...
(Date:3/24/2017)... and GENEVA , March 24, ... World Tuberculosis Day revitalizes efforts to develop sutezolid as ... On World Tuberculosis Day, TB Alliance and the Medicines ... clinical development of sutezolid, an antibiotic drug candidate which ... to the development of sutezolid in combination with other ...
Breaking Medicine Technology: